Hospira, Inc. (HSP)'s Lidocaine Injection Recalled In 28 States
12/27/2013 7:03:08 AM
Hospira Inc. has initiated a voluntary nationwide recall to the user level for one lot of Lidocaine HCl Injection because of a reddish orange particulate on the inner surface and floating in the solution. The recalled lot is Lidocaine HCl, USP, 2%, 5 mL single-dose vial (NDC 0409-2066-05), Lot 32-135-DD, expiration date Aug. 1, 2015. Lidocaine is packaged 10 units per carton/180 units per case in single dose glass fliptop vials.
Help employers find you! Check out all the jobs and post your resume.
comments powered by